NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 324 filers reported holding NEOGENOMICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $934,359 | -29.3% | 53,668 | -65.0% | 0.00% | -50.0% |
| Q3 2022 | $1,321,000 | +68.5% | 153,441 | +59.6% | 0.00% | +100.0% |
| Q2 2022 | $784,000 | -51.4% | 96,158 | +103.4% | 0.00% | -50.0% |
| Q4 2021 | $1,613,000 | +150.1% | 47,264 | +231.0% | 0.00% | +100.0% |
| Q2 2021 | $645,000 | -86.6% | 14,277 | -85.6% | 0.00% | -83.3% |
| Q1 2021 | $4,796,000 | -16.2% | 99,445 | -6.4% | 0.01% | -25.0% |
| Q4 2020 | $5,721,000 | +64.2% | 106,261 | +12.5% | 0.01% | +33.3% |
| Q3 2020 | $3,484,000 | -15.6% | 94,449 | -29.2% | 0.01% | -14.3% |
| Q2 2020 | $4,130,000 | +50.6% | 133,309 | +34.2% | 0.01% | +16.7% |
| Q1 2020 | $2,743,000 | +172.9% | 99,356 | +189.2% | 0.01% | +200.0% |
| Q4 2019 | $1,005,000 | -56.2% | 34,353 | -71.3% | 0.00% | -50.0% |
| Q3 2019 | $2,292,000 | -40.5% | 119,859 | -31.8% | 0.00% | -42.9% |
| Q2 2019 | $3,853,000 | +33.0% | 175,636 | +24.1% | 0.01% | +16.7% |
| Q1 2019 | $2,896,000 | +23.1% | 141,552 | -24.1% | 0.01% | 0.0% |
| Q4 2018 | $2,353,000 | – | 186,562 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |